首页> 外国专利> PHARMACEUTICAL COMPOSITION CONTAINING RAMIPRIL AND TELMISARTAN OR VALSARTAN FOR REDUCING BLOOD PRESSURE

PHARMACEUTICAL COMPOSITION CONTAINING RAMIPRIL AND TELMISARTAN OR VALSARTAN FOR REDUCING BLOOD PRESSURE

机译:包含拉米普利和替米沙坦或缬沙坦的药物组合物,可降低血压

摘要

PURPOSE: A pharmaceutical composition containing ramipril and telmisartan or valsartan is provided to ensure effective blood pressure reduction and to suppress heart damage.;CONSTITUTION: A pharmaceutical composition for reducing blood pressure contains effective amount of ramipril and telmisartan or valsartan as an active ingredient. A pharmaceutical composition contains 0.312-5 mg of ramipril and 10-160mg of valsartan. A pharmaceutical composition contains 0.312-5mg and 5-80 mg of telmisartan. The pharmaceutical composition is used in the oral formulation. The pharmaceutical composition is used in treating or preventing hypertension, cardiac insufficiency, arteria coronaria atresia choanae, ischemic heart disease, ischemic peripheral circulatory system disease, hypertensive renal failure, stroke or artery scleroma.;COPYRIGHT KIPO 2010
机译:目的:提供一种包含雷米普利和替米沙坦或缬沙坦的药物组合物,以确保有效降低血压并抑制心脏损害。;组成:一种降低血压的药物组合物,包含有效量的雷米普利和替米沙坦或缬沙坦作为有效成分。药物组合物包含0.312-5mg雷米普利和10-160mg缬沙坦。药物组合物包含0.312-5mg和5-80mg替米沙坦。该药物组合物用于口服制剂。该药物组合物用于治疗或预防高血压,心脏功能不全,冠状动脉闭锁性脉络膜炎,缺血性心脏病,缺血性外周循环系统疾病,高血压肾衰竭,中风或动脉硬化。COPYRIGHTKIPO 2010

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号